Effectiveness of Acceptance and Commitment Therapy on Depression and Anxiety of ADHD Childrens' Mothers

The presence of a child with ADHD in families can lead to mothers' depression and anxiety, the sense of limiting the role of parents and the sense of inadequacy in child rearing in ADHD children's families. In this study، a quasi-experimental pre test- post test control group، the sample of sample available from mothers of ADHD children referred counseling clinic in sanandaj، among them، 30 persons were randomly 15 experimentrol groups were divided in the pre-test، in order to measure anxiety and depreeion، the Beck Depression and Anxiety Inventory and for assessing symptoms of ADHD children kaners parent questionnaire was used. The experimental group received 8 sessions of 2 hours Acceptance and Commitment Therapy, and the control group recived not treatment in the pre-test، questinaires were administered to both groups at post test. The results showed that in the post-test scores significantiy decreased depression and anxiety. Therfore، Acceptance and Commitment Therapy، the treatment of depression and anxiety in mothers of ADHD children has been effective. The results emphasize the importance of using these interventions in depressions and anxiety in mothers of children with ADHD and provide new horizons in clinical interventions from mothers and children is emphasized for these patients

Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease

<div><p>Background and Aims</p><p>The substantial characteristics of Irritable Bowel Syndrome (IBS) are associated with estrogens in women. Both soy isoflavones and vitamin D can modulate estrogen receptors in the colonic smooth muscles. The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.</p><p>Methods</p><p>In a factorial blinded randomized clinical trial, 100 women with IBS (age:18-75yr, were randomly assigned in 4 arms to receive either placebo of vitamin D and placebo of soy isoflavones (P+P), or placebo of vitamin D and soy isoflavones (P+S), or vitamin D and placebo of soy isoflavones (D+P), or vitamin D and soy isoflavones (D+S) for 6 weeks. Dosage of soy isoflavone was 2 capsules of 20 mg soy isoflavones per day, and dosage of vitamin D was one pearl of 50’000 IU biweekly. The clinical outcomes were IBS symptoms severity scores (IBS-SSS), disease- specific quality of life (IBS-QOL) and total score (IBS-TS) that evaluated at weeks 0, 6, and 10, and compared to each other.</p><p>Results</p><p>IBS-TS improved significantly in both S+P and D+P groups (p- value = 0.004, 0.015). The interaction effect of soy isoflavones and vitamin D on IBS-TS was significant (p<0.05). The interaction effect of soy isoflavones with vitamin D and the main effect of vitamin D on IBS-SSS were not statistically significant, whereas IBS-SSS decreased significantly in S+P and D+P groups (p-value = 0.001, 0.047 respectively).</p><p>Conclusion</p><p>Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS- SSS and IBS- QOL; however, it improved the IBS-TS.</p><p>Trial Registration</p><p>Clinical Trials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT02026518?term=NCT02026518&rank=1" target="_blank">NCT02026518</a></p></div

The effects of soy isoflavones and/or vitamin D supplementation on abdominal distension after 6 weeks; results are adjusted for the baseline values and IBS subtype.

<p>S+P: soy isoflavones and placebo of vitamin D group, S+D: soy isoflavones and vitamin D group, P+P: placebo of soy isoflavones and placebo of vitamin D group, D+P: vitamin D and placebo of soy isoflavones group.* pso of v.</p

The effects of soy isoflavones or/ and vitamin D on the total score of IBS after 6 weeks.

<p>The effects of soy isoflavones or/ and vitamin D on the total score of IBS after 6 weeks.</p

Flow Diagram of the study.

<p>Flow Diagram of the study.</p

The effects of soy isoflavones and/or vitamin D supplementation on satisfaction of bowel habits after 6 weeks; results are adjusted for the baseline values and IBS subtype.

<p>S+P: soy isoflavones and placebo of vitamin D group, S+D: soy isoflavones and vitamin D group, P+P: placebo of soy isoflavones and placebo of vitamin D group, D+P: vitamin D and placebo of soy isoflavones group.* pso of v.</p

The effects of soy isoflavones and/or vitamin D supplementation on abdominal pain duration after 6 weeks; results are adjusted for the baseline values and IBS subtype.

<p>S+P: soy isoflavones and placebo of vitamin D group, S+D: soy isoflavones and vitamin D group, P+P: placebo of soy isoflavones and placebo of vitamin D group, D+P: vitamin D and placebo of soy isoflavones group.* pso of v.</p

Characteristics of participants in different groups at the baseline.

<p>Characteristics of participants in different groups at the baseline.</p

The effects of soy isoflavones and/or vitamin D supplementation on life disruption after 6 weeks; results are adjusted for the baseline values and IBS subtype.

<p>S+P: soy isoflavones and placebo of vitamin D group, S+D: soy isoflavones and vitamin D group, P+P: placebo of soy isoflavones and placebo of vitamin D group, D+P: vitamin D and placebo of soy isoflavones group.* pso of v</p

Estimation of effect of vitamin D on total score in Placebo and Soy isoflavones groups separately.

<p>Estimation of effect of vitamin D on total score in Placebo and Soy isoflavones groups separately.</p